Angiogenic factors regulate adhesion of activated natural killer cells to the tumor vasculature (pages 992-997).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Inhibition of the alpha-ν integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo
British Journal of Cancer Open Access 26 February 2002
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Berke, G. The function and mechanism of action of cytolytic lymphocytes. in Fundamental Immunology, 3rd edn. (ed. Paul, W.E.) 965–1014 1993.
Rosenberg, S. Adoptive immunotherapy for cancer. Sci. Am. 262(5), 62 69 1990
Parmiani, G. An explanation of the variable clinical response to interleukin 2 and LAK cells. Immunol. Today 11, 113–115 1990).
Sasaki, A., Melder, R.J., Whiteside, T.L., Herberman, R.B., Jain, R.K. Preferential localization of human adherent lymphokineactivated killer cells in tumor microcirculation. j.Natl. CancerInst. 83, 433–437 1991.
Melder, R.J., Brownell, A.L., Shoup, T.M., Brownell, G.L., Jain, R.K. Imaging of activatednatural killer cells in mice by positron emissiontomography: Preferential up take in tumors. Cancer Res. 53, 5876–5881 1993.
Jain, R.K. et al. Leukocyte-endothelial adhesionand angiogenesis in tumors. Cancer MetastasisRev. 15, 195–1004 1996.
Melder, R.J. et al. During angiogenesis, vascularendothelial growth factor and basic fibroblastgrowth factor regulate natural killer cell adhesion to tumor endothelium. Nature Med. 2, 992–997 1996
Pepper, M.S. Ferrara, N., Montesano, R., Orci, L. potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. 189, 824–831 1992.
Asahara, T. et al. Synergistic effects of VEGF andbFGF on angiogenesis in vivo. Circulation 92, 365–371 1995.
Kim, K.J. et al. Inhibition of vascular endothelial growth factor–induced angiogenesis suppressestumour growth in vivo. Nature 362, 841–844 1993.
Winter, B.K., Wu, S., Nelson, A.C., Pollack, S.B. Renal cell carcinoma and natural killer activity:Studies in a novel rat model in vitro and in vivo. Cancer Res. 52, 6279–6286 1992.
Ferrara, N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res. Treat. 36, 127–132 1995.
Koch, A.E., Halloran, M.M., Haskell, C.K., Isnm, M.R. & Polverini, P.J. Angiogenesis mediated bysoluble forms of E-selectin and vascular adhesionmolecule-1. Nature 376, 517–519 1996.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ferrara, N. Natural killer cells, adhesion and tumor angiogenesis. Nat Med 2, 971–972 (1996). https://doi.org/10.1038/nm0996-971
Issue Date:
DOI: https://doi.org/10.1038/nm0996-971
This article is cited by
-
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions
Cancer and Metastasis Reviews (2008)
-
Inhibition of the alpha-ν integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo
British Journal of Cancer (2002)
